Assessment of COVID-19 related Fatalities in Tertiary Care Hospitals of Rawalpindi Medical University Pakistan
Objectives: To assess the COVID-19 associated fatalities with respect to demographics, comorbidity, critical illness and length of hospital stay in tertiary care hospitals.
Subjects & Methods: A retrospective hospital data based research was done among 216 COVID-19 associated mortalities registered in 4 tertiary care hospitals Holy Family Hospital (HFH), Benazir Bhutto Hospital (BBH), District Head Quarters Hospital (DHQ) and Rawalpindi Institute of Urology & Transplantation (RIU & T) affiliated with Rawalpindi Medical University from 29th March-15th June 2020. The data was gathered by consecutive sampling pertinent to demographics, hospital stay, comorbidity, critical illness and ventilator or oxygen support. The length of hospital stay among fatalities with and without comorbidity was compared by independent sample z-test. Data was analyzed by using SPSS version 25.0.
Results: Of the total 216 COVID-19 related mortalities, 150(69.4%) were males and 66(30.6%) were females. Mean age of fatalities was 55.66 ± 13.97 years. About 76.7% dying males were 41-70 years old while 56.1% females dying of COVID-19 were 41-60 years old. Most (60.8%) of study subjects had hypertension followed by diabetes (53.8%), Ischemic Heart Disease (17.5%) and respiratory disorders (12.3%). About 75% of the critically ill patients needed ventilator for respiratory support. Length of hospital stay was determined to have statistically insignificant association (P > 0.10) with presence or absence of comorbidity among COVID-19 patients. Critical illness had highly significant association (P < 0.000) with ventilator support among COVID-19 related mortalities.
Conclusion: People 41-70 years should preferably adopt stringent precautions for protection against COVID-19. Comorbid states chiefly hypertension, diabetes, cardiac and respiratory diseases need special consideration amid COVID-19 pandemic to abstain from adverse health outcomes.
2. Wilson ME, Chen LH. Travelers give wings to novel Coronavirus (2019-nCoV). J Travel Med 2020; 27:01. doi: 10.1093/jtm/taaa015.
3. Wu JT, K. L, Leung GM. Now casting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020: 10.1016/S0140-6736(20)30260-9.
4. Du R-H, Liang L-R, Yang C-Q, Wang W, Cao T-Z, Li M, et al. Predictors of Mortality for patients with COVID-19 pneumonia caused by SARS-COV-2: A prospective cohort study. Eur Respir J 2020. (https://doi.org/10.1183/13993003.00524-2020).
5. Javed B, Sarwer A, Soto EB, Mashwani Z. Is Pakistan’s response to Coronavirus (SARS CoV-2) adequate to prevent an outbreak? Front. Med 21 April 2020. https://doi.org/10.3389/fmed.2020.00158.
6. Countries where COVID-19 has spread. Available at: https://www.worldometers.info/coronavirus/countries-where-coronavirus-has-spread/.
7. Waris A, Atta UK, Ali M, Asmat A, Baset A. COVID-19 Outbreak: Current Scenario of Pakistan. New Microbe and New Infect 2020; 35: 1-6. https://doi.org/1016/j.nmni.2020.100681.
8. COVID-19 cases in Pakistan latest. Available at: https://www.google.com/search?q=covid+19+cases+in+pakistan+latest&rlz=1C1GCEA_enPK861PK861&oq=covid+19+cases+in+pakistan+latest+&aqs=chrome..69i57.18471j0j7&sourceid=chrome&ie=UTF-8.
9. Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Guti_errez-Ocampo, E., Villamizar-Pena, R., Holguin-Rivera, Y., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease, 101623 (2020). doi:10.1016/j.tmaid.2020.101623
10. .Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of General Internal Medicine 2020. doi:10.1007/s11606-020-05762-w.
11. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239-1242. doi:10.1001/jama.2020.2648.
12. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo, Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. International Journal of Infectious Diseases 94, 91-95 (2020). doi:10.1016/j.ijid.2020.03.017.
13. World Health Organization. Rolling Updates on coronavirus disease (COVID-19). Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
14. Coronavirus (COVID-19) Mortality Rate. Available at: https://www.worldometers.info/coronavirus/coronavirus-death-rate/.
15. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775.
16. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front. Public Health 2020; 8:152.doi: 10.3389/fpubh.2020.00152.
17. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020: E1-E2. https://jamanetwork.com/.
18. Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. International Journal of Infectious Diseases 2020; 93: 339-344. https://doi.org/10.1016/j.ijid.2020.03.031.
19. Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CAB. COVID-19 length of hospital stay: a systematic review and data synthesis. doi: https://doi.org/10.1101/2020.04.30.20084780.
20. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet 2020; 395: 1054-1062.
21. Auld SC, Caridi-Scheible M, Blum JM, Robichaux C, Kraft C, Jacob JT, et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Critical Care Medicine 2020. XX (XXX): 1-6. DOI: 10.1097/CCM.0000000000004457.
Copyright (c) 2020 Rizwana Shahid
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.